PRODUCTION OF MORANOLINE DERIVATIVE
PURPOSE:To obtain a glucosylmoranoline derivative useful as a remedy for diabetes in high yield in high purity, by subjecting a mixture of the glucosylmoranoline derivative and an oliglucosylmoranoline derivative, etc. to fractionating crystallization in method using a polar solvent. CONSTITUTION:A...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KAWAMATA MASANOBU KOJIMA NOBUTOSHI EZURE YOJI MIYAZAKI KATSUNORI |
| description | PURPOSE:To obtain a glucosylmoranoline derivative useful as a remedy for diabetes in high yield in high purity, by subjecting a mixture of the glucosylmoranoline derivative and an oliglucosylmoranoline derivative, etc. to fractionating crystallization in method using a polar solvent. CONSTITUTION:A mixture of a moranoline derivative shown by the formula I (R is H, or lower alkyl), a glucosylmoranoline derivative shown by the formula II, and a glucosylmoranoline derivative shown by the formula III (n is 1-5) is dissolved in a polar solvent (e.g., water, methanol, etc.), usually insoluble materials are filtered off, the filtrate is allowed to stand or cooled, to crystallize the glucosyl-momoranoline derivative shown by the formula II. The mixture of the derivatives is obtained by treating an aqueous solution containing the moranoline derivative and cyclodextrin, etc., with cyclodextrin glycosyltransferase. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPS61115093A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPS61115093A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPS61115093A3</originalsourceid><addsrcrecordid>eNrjZFAOCPJ3CXUO8fT3U_B3U_D1D3L08_fx9HNVcHEN8gxzDPEMc-VhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfFeAcFmhoaGpgaWxo7GxKgBAHpfIzk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PRODUCTION OF MORANOLINE DERIVATIVE</title><source>esp@cenet</source><creator>KAWAMATA MASANOBU ; KOJIMA NOBUTOSHI ; EZURE YOJI ; MIYAZAKI KATSUNORI</creator><creatorcontrib>KAWAMATA MASANOBU ; KOJIMA NOBUTOSHI ; EZURE YOJI ; MIYAZAKI KATSUNORI</creatorcontrib><description>PURPOSE:To obtain a glucosylmoranoline derivative useful as a remedy for diabetes in high yield in high purity, by subjecting a mixture of the glucosylmoranoline derivative and an oliglucosylmoranoline derivative, etc. to fractionating crystallization in method using a polar solvent. CONSTITUTION:A mixture of a moranoline derivative shown by the formula I (R is H, or lower alkyl), a glucosylmoranoline derivative shown by the formula II, and a glucosylmoranoline derivative shown by the formula III (n is 1-5) is dissolved in a polar solvent (e.g., water, methanol, etc.), usually insoluble materials are filtered off, the filtrate is allowed to stand or cooled, to crystallize the glucosyl-momoranoline derivative shown by the formula II. The mixture of the derivatives is obtained by treating an aqueous solution containing the moranoline derivative and cyclodextrin, etc., with cyclodextrin glycosyltransferase.</description><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; SUGARS</subject><creationdate>1986</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19860602&DB=EPODOC&CC=JP&NR=S61115093A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19860602&DB=EPODOC&CC=JP&NR=S61115093A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KAWAMATA MASANOBU</creatorcontrib><creatorcontrib>KOJIMA NOBUTOSHI</creatorcontrib><creatorcontrib>EZURE YOJI</creatorcontrib><creatorcontrib>MIYAZAKI KATSUNORI</creatorcontrib><title>PRODUCTION OF MORANOLINE DERIVATIVE</title><description>PURPOSE:To obtain a glucosylmoranoline derivative useful as a remedy for diabetes in high yield in high purity, by subjecting a mixture of the glucosylmoranoline derivative and an oliglucosylmoranoline derivative, etc. to fractionating crystallization in method using a polar solvent. CONSTITUTION:A mixture of a moranoline derivative shown by the formula I (R is H, or lower alkyl), a glucosylmoranoline derivative shown by the formula II, and a glucosylmoranoline derivative shown by the formula III (n is 1-5) is dissolved in a polar solvent (e.g., water, methanol, etc.), usually insoluble materials are filtered off, the filtrate is allowed to stand or cooled, to crystallize the glucosyl-momoranoline derivative shown by the formula II. The mixture of the derivatives is obtained by treating an aqueous solution containing the moranoline derivative and cyclodextrin, etc., with cyclodextrin glycosyltransferase.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1986</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAOCPJ3CXUO8fT3U_B3U_D1D3L08_fx9HNVcHEN8gxzDPEMc-VhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfFeAcFmhoaGpgaWxo7GxKgBAHpfIzk</recordid><startdate>19860602</startdate><enddate>19860602</enddate><creator>KAWAMATA MASANOBU</creator><creator>KOJIMA NOBUTOSHI</creator><creator>EZURE YOJI</creator><creator>MIYAZAKI KATSUNORI</creator><scope>EVB</scope></search><sort><creationdate>19860602</creationdate><title>PRODUCTION OF MORANOLINE DERIVATIVE</title><author>KAWAMATA MASANOBU ; KOJIMA NOBUTOSHI ; EZURE YOJI ; MIYAZAKI KATSUNORI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPS61115093A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1986</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>KAWAMATA MASANOBU</creatorcontrib><creatorcontrib>KOJIMA NOBUTOSHI</creatorcontrib><creatorcontrib>EZURE YOJI</creatorcontrib><creatorcontrib>MIYAZAKI KATSUNORI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KAWAMATA MASANOBU</au><au>KOJIMA NOBUTOSHI</au><au>EZURE YOJI</au><au>MIYAZAKI KATSUNORI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PRODUCTION OF MORANOLINE DERIVATIVE</title><date>1986-06-02</date><risdate>1986</risdate><abstract>PURPOSE:To obtain a glucosylmoranoline derivative useful as a remedy for diabetes in high yield in high purity, by subjecting a mixture of the glucosylmoranoline derivative and an oliglucosylmoranoline derivative, etc. to fractionating crystallization in method using a polar solvent. CONSTITUTION:A mixture of a moranoline derivative shown by the formula I (R is H, or lower alkyl), a glucosylmoranoline derivative shown by the formula II, and a glucosylmoranoline derivative shown by the formula III (n is 1-5) is dissolved in a polar solvent (e.g., water, methanol, etc.), usually insoluble materials are filtered off, the filtrate is allowed to stand or cooled, to crystallize the glucosyl-momoranoline derivative shown by the formula II. The mixture of the derivatives is obtained by treating an aqueous solution containing the moranoline derivative and cyclodextrin, etc., with cyclodextrin glycosyltransferase.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_JPS61115093A |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY SUGARS |
| title | PRODUCTION OF MORANOLINE DERIVATIVE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T11%3A35%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KAWAMATA%20MASANOBU&rft.date=1986-06-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPS61115093A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |